Compare · ALC vs EYE
ALC vs EYE
Side-by-side comparison of Alcon Inc. (ALC) and National Vision Holdings Inc. (EYE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALC and EYE operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- ALC is the larger of the two at $36.66B, about 24.8x EYE ($1.48B).
- Over the past year, ALC is down 9.9% and EYE is down 23.9% - ALC leads by 14.0 points.
- EYE has been more active in the news (8 items in the past 4 weeks vs 3 for ALC).
- ALC has more recent analyst coverage (25 ratings vs 20 for EYE).
- Company
- Alcon Inc.
- National Vision Holdings Inc.
- Price
- $73.37-0.47%
- $18.68+2.55%
- Market cap
- $36.66B
- $1.48B
- 1M return
- +9.04%
- -10.08%
- 1Y return
- -9.93%
- -23.89%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2017
- News (4w)
- 3
- 8
- Recent ratings
- 25
- 20
Alcon Inc.
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; and EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
National Vision Holdings Inc.
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. As of January 2, 2021, the company operated through 1,205 retail stores, as well as various e-commerce websites. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.
Latest ALC
- Alcon downgraded by BNP Paribas Exane with a new price target
- SEC Form 6-K filed by Alcon Inc.
- New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
- Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
- SEC Form SD filed by Alcon Inc.
- SEC Form 6-K filed by Alcon Inc.
- New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
- Alcon Announces Results of 2026 Annual General Meeting
- Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada
- Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs, at ASCRS 2026
Latest EYE
- Chief Executive Officer Wilkes Alexander converted options into 61,786 shares and covered exercise/tax liability with 29,884 shares, increasing direct ownership by 136% to 55,441 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by National Vision Holdings Inc.
- SEC Form 10-Q filed by National Vision Holdings Inc.
- National Vision Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- National Vision Holdings, Inc. Reports Second Quarter 2026 Financial Results
- Amendment: SEC Form SCHEDULE 13G/A filed by National Vision Holdings Inc.
- SEC Form SCHEDULE 13G filed by National Vision Holdings Inc.
- Chief Executive Officer Wilkes Alexander converted options into 13,768 shares and covered exercise/tax liability with 6,660 shares, increasing direct ownership by 43% to 23,539 units (SEC Form 4)
- National Vision Holdings, Inc. Announces Second Quarter 2026 Earnings Release and Conference Call
- President, America's Best Banner Mark converted options into 11,728 shares and covered exercise/tax liability with 4,964 shares, increasing direct ownership by 38% to 24,603 units (SEC Form 4)